Florian von der Muelbe
Gründer bei CureVac SE
Ursprung des Netzwerks ersten Grades von Florian von der Muelbe
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
22
| Subsidiary | Biotechnology | 22 |
18
| Public Company | Pharmaceuticals: Major | 18 |
CureVac Real Estate GmbH
 CureVac Real Estate GmbH Real Estate DevelopmentFinance CureVac Real Estate GmbH manages commercial and non-residential buildings. The company is headquartered in Tuebingen, Germany.
1
| Subsidiary | Real Estate Development | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Florian von der Muelbe
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| 2INVEST AG | Financial Conglomerates | Director/Board Member Compliance Officer | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
| GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Corporate Officer/Principal | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Universität des Saarlandes | College/University | Doctorate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
| SCHRÖDINGER, INC. | Packaged Software | Director/Board Member | |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Biotechnology | Corporate Officer/Principal | |
Lion Bioscience, Inc.
 Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | General Counsel | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
International Vaccine Institute
 International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Chief Executive Officer | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GEUDER AG
 GEUDER AG Medical SpecialtiesHealth Technology GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
| The University of North Carolina at Charlotte | College/University | Masters Business Admin | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
dievini patch Beteiligungs GmbH
 dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Financial Conglomerates | Chief Executive Officer | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Founder | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Real Estate Development | Chief Executive Officer | |
| African Research Excellence Fund | Director/Board Member | ||
Meininger Verlag GmbH
 Meininger Verlag GmbH Publishing: Books/MagazinesConsumer Services Meininger Verlag GmbH provides the latest news and tasting results from the wine and beverage industry. The private company is based in Neustadt, Germany. The German company offers information on the best wines, beers, and spirits. The CEOs are Wolfgang Heckmann, Horst Emmert, Ralf Clemens. The company was founded in 1903 by Daniel Meininger. | Publishing: Books/Magazines | Chief Executive Officer | |
| Hmm Consulting | Chief Executive Officer | ||
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| CLOVER BIOPHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
Mindfactory AG
 Mindfactory AG Electronics DistributorsDistribution Services Mindfactory AG is an online retailer that specializes in selling a wide range of hardware, software, notebooks, computers, tablets, smartphones, and game consoles. The private company was founded in 1996 and is based in Wilhelmshaven, Germany. | Electronics Distributors | Chairman | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member |
Statistik
International
| Deutschland | 23 |
| Vereinigte Staaten | 10 |
| Belgien | 9 |
| Italien | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 24 |
| Finance | 8 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 118 |
| Corporate Officer/Principal | 51 |
| Chairman | 41 |
| Chief Executive Officer | 29 |
| Independent Dir/Board Member | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Baron Jean Stéphenne | 36 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Mathias Hothum | 19 |
| Michael Brosnan | 14 |
| Ralf Clemens | 14 |
| Timothy M. Wright | 13 |
| Daniel L. Menichella | 13 |
| Jean Stephenne | 12 |
| Debra Stephanie Barker | 11 |
| Franz-Werner Haas | 9 |
| Igor Splawski | 8 |
| Viola Bronsema | 7 |
| Bernd Winterhalter | 5 |
- Börse
- Insiders
- Florian von der Muelbe
- Unternehmensverbindungen